Increase in the pharmacological management of Type 2 diabetes with pay-for-performance in primary care in the UK

Diabetic Medicine

Volumn 32, Issue 1, 2015, Pages 62-68

  Gallagher, N ^a   Cardwell, C ^a   Hughes, C ^a   O'Reilly, D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; FEMALE; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACEUTICAL CARE; PRIMARY MEDICAL CARE; SECONDARY ANALYSIS; UNITED KINGDOM; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; ECONOMICS; GENERAL PRACTICE; HEALTH CARE QUALITY; METABOLISM; MULTICENTER STUDY; PERSONNEL MANAGEMENT; PRIMARY HEALTH CARE; REIMBURSEMENT; TOTAL QUALITY MANAGEMENT;

DIABETES MELLITUS, TYPE 2; FEMALE; GENERAL PRACTICE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; PHYSICIAN INCENTIVE PLANS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE; REIMBURSEMENT, INCENTIVE;

EID: 84916608190     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12575     Document Type: Article

References (30)

1. Rosenthal MB, Fernandopulle R, Song HR, Landon B. Paying For Quality: Providers' Incentives For Quality Improvement. Health Aff (Millwood) 2004; 23: 127-141.
2. Epstein A, Lee T, Hamel M. Paying physicians for high-quality care. N Engl J Med 2004; 350: 406-410.
3. Gosden T, Forland F, Kristiansen IS, Sutton M, Leese B, Giuffrida A et al. Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane Database Syst Rev 2000;(3):CD002215.
4. Rosenthal MB, Frank RG. What is the empirical basis for paying for quality in health care? Med Care Res Rev 2006; 63: 135-157.
5. Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M. Effects of pay for performance on the quality of primary care in England. N Engl J Med 2009; 361: 368-378.
6. Stratton IIM, Adler AIA, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
7. National Clinical Guideline for Management in Primary and Secondary Care (Update). NICE Clinical Guidelines, No. 66. National Collaborating Centre for Chronic Conditions (UK). London: Royal College of Physicians (UK), 2008. Available at http://www.rcplondon.ac.uk/Pages/index.aspx Last accessed 20 June 2014.
8. Christianson JB, Leatherman S, Sutherland K. Lessons from evaluations of purchaser pay-for-performance programs: a review of the evidence. Med Care Res Rev 2008; 65: 5S-35S.
9. Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does Pay-for-Performance Improve the Quality of Health Care? Ann Intern Med 2006; 145: 265-272.
10. Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev 2011; (9):CD008451.
11. Khunti K, Gadsby R, Millett C, Majeed A, Davies M. Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med 2007; 24: 1436-1441.
12. Campbell SM, Roland MO, Middleton E, Reeves D. Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study. BMJ 2005; 331: 1121.
13. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ 2009; 338: b1870.
14. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin RD, Zinman B. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972.
15. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32: S13-61.
16. SIGN 116: Management of diabetes - A national clinical guideline. Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland, 2010. Available at http://www.sign.ac.uk/guidelines/fulltext/116/; Last accessed 20 June 2014.
17. Hippisley-Cox J, Pringle M. Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey. Lancet 2004; 364: 423-428.
18. Parkinson J, Davis S, Van Staa TP. The General Practice Research Database: Now and the Future. In: Mann RD, Andrews EB, eds. Pharmacovigilance, 2nd edn. Chichester: John Wiley & Sons, Ltd, 2007: 341-348.
19. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodríguez LA, Ruigómez A, Meier CR et al. Validity of the general practice research database. Pharmacotherapy 2003; 23: 686-689.
20. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60: e128-36.
21. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69: 4-14.
22. The Comptroller and Auditor General, National Audit Office. NHS Pay Modernisation: New Contracts for General Practice Services in England. House of Commons Committee of Public Accounts. Forty-first report of session, 2007-08. Published on 9 October 2008 by authority of the House of Commons London: The Stationery Office Limited.
23. Alshamsan R, Millett C, Majeed A, Khunti K. Has pay for performance improved the management of diabetes in the United Kingdom? Prim Care Diabetes 2010; 4: 73-78.
24. Vaghela P, Ashworth M, Schofield P, Gulliford MC. Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008. Diabetes Care 2009; 32: 427-429.
25. Tahrani AA, McCarthy M, Godson J, Taylor S, Slater H, Capps N, et al. Diabetes care and the new GMS contract: the evidence for a whole county. Br J Gen Pract 2007; 57: 483-485.
26. Gulliford MC, Ashworth M, Robotham D, Mohiddin A. Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives. Diabet Med 2007; 24: 505-511.
27. Lusignan S, Sismanidis C, Carey IM, DeWilde S, Richards N, Cook DG. Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and Wales. BMC Fam Pract 2005; 6: 13.
28. Millett C, Netuveli G, Saxena S, Majeed A. Impact of pay for performance on ethnic disparities in intermediate outcomes for diabetes: a longitudinal study. Diabetes Care 2009; 32: 404-409.
29. Sutton M, Elder R, Guthrie B, Watt G. Record rewards: the effects of targeted quality incentives on the recording of risk factors by primary care providers. Health Econ 2010; 19: 1-13.
30. Kontopantelis E, Reeves D, Valderas JM, Campbell S, Doran T. Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: a longitudinal observational study. BMJ Qual Saf 2013; 22: 53-64.